Health disparities are one of the most important public health challenges in the United States. Disparities and inequities in rates and treatment of disease stem from a complex web of environmental, sociocultural, behavioral, and biological factors that accumulate over a lifetime to produce population-level differences.1 As evidenced by the COVID-19 pandemic, health disparities result in markedly different rates of disease, complications of disease, and access to care and treatment. In the US, Alzheimer disease and related dementias are conditions with profound health disparities, disproportionally affecting many racial/ethnic groups. An identified goal of the 2012 federally mandated National Plan to Address Alzheimer Disease was to redress disparities in Alzheimer disease and dementia. Delineating barriers and trajectories of care, particularly among those with health insurance, is an important step for furthering our understanding of disparities in dementia.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Kawas CH, Corrada MM, Whitmer RA. Diversity and Disparities in Dementia Diagnosis and Care: A Challenge for All of Us. JAMA Neurol. 2021;78(6):650–652. doi:10.1001/jamaneurol.2021.0285
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: